Literature DB >> 22802465

Elevated urinary catecholamines and adrenal haemorrhage mimicking phaeochromocytoma.

Simon Wordsworth1, Ben Thomas, Neera Agarwal, Kate Hoddell, Steve Davies.   

Abstract

A 51-year-old woman was admitted with left-sided flank pain initially thought to be renal colic. However, a CT urogram was normal. During the course of the admission the pain persisted and she developed severe sustained hypertension. A repeat CT scan of the abdomen revealed a 5×3 cm left adrenal abnormality consistent with haemorrhage, not seen on the original scan. Further assessment revealed elevated urine catecholamines and a short synacthen test showed a suboptimal cortisol response. The diagnosis was initially considered as a phaeochromocytoma, she received phenoxybenzamine with good resolution of hypertension and was referred for surgical opinion. However, serial urinary catecholamine concentrations returned to within the normal range and the diagnosis was revised to adrenal infarction and haemorrhage due to antiphospholipid syndrome. This case illustrates the importance of recognising adrenal infarction as a potential cause of 'pseudophaeochromocytoma'.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 22802465      PMCID: PMC3029957          DOI: 10.1136/bcr.01.2010.2612

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  11 in total

Review 1.  Corticosteroid insufficiency in acutely ill patients.

Authors:  Mark S Cooper; Paul M Stewart
Journal:  N Engl J Med       Date:  2003-02-20       Impact factor: 91.245

Review 2.  Clinical review 164: The laboratory diagnosis of adrenal pheochromocytoma: the Mayo Clinic experience.

Authors:  Yogish C Kudva; Anna M Sawka; William F Young
Journal:  J Clin Endocrinol Metab       Date:  2003-10       Impact factor: 5.958

3.  Potential pitfalls in the diagnosis of phaeochromocytoma.

Authors:  Jane L Harding; Michael W Yeh; Bruce G Robinson; Leigh W Delbridge; Stan B Sidhu
Journal:  Med J Aust       Date:  2005-06-20       Impact factor: 7.738

4.  Dietary influences on plasma and urinary metanephrines: implications for diagnosis of catecholamine-producing tumors.

Authors:  Wilhelmina H A de Jong; Graeme Eisenhofer; Wendy J Post; Frits A J Muskiet; Elisabeth G E de Vries; Ido P Kema
Journal:  J Clin Endocrinol Metab       Date:  2009-06-30       Impact factor: 5.958

5.  Definitive adrenal insufficiency due to bilateral adrenal hemorrhage and primary antiphospholipid syndrome.

Authors:  P Caron; M H Chabannier; J P Cambus; F Fortenfant; P Otal; J M Suc
Journal:  J Clin Endocrinol Metab       Date:  1998-05       Impact factor: 5.958

6.  Transient hypertension due to adrenal hemorrhage in a patient with von Recklinghausen's disease.

Authors:  N Akuzawa; T Nakamura; A Tanaka; S Ikeda; T Fukuda; T Sakamaki; R Nagai
Journal:  Intern Med       Date:  1997-04       Impact factor: 1.271

7.  Posttraumatic hypertension secondary to adrenal hemorrhage mimicking pheochromocytoma: case report.

Authors:  J Schmidt; V D Mohr; P Metzger; H Zirngibl
Journal:  J Trauma       Date:  1999-05

8.  Pattern of elevation of urine catecholamines in intracerebral haemorrhage.

Authors:  G F Hamann; M Strittmatter; K H Hoffmann; G Holzer; M Stoll; T Keshevar; R Moili; K Wein; K Schimrigk
Journal:  Acta Neurochir (Wien)       Date:  1995       Impact factor: 2.216

Review 9.  Clinical update on the management of adrenal hemorrhage.

Authors:  Daniel R Simon; Michael A Palese
Journal:  Curr Urol Rep       Date:  2009-01       Impact factor: 3.092

10.  Pseudophaeochromocytoma in two young Africans.

Authors:  O E Okosieme; R E Morse
Journal:  J R Soc Med       Date:  2004-12       Impact factor: 18.000

View more
  1 in total

1.  Adrenal bleeding due to pheochromocytoma - A call for algorithm.

Authors:  Ewelina Rzepka; Joanna Kokoszka; Anna Grochowska; Magdalena Ulatowska-Białas; Martyna Lech; Marta Opalińska; Elwira Przybylik-Mazurek; Aleksandra Gilis-Januszewska; Alicja Hubalewska-Dydejczyk
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-05       Impact factor: 6.055

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.